What is Brief History of Perrigo Company Company?

Perrigo Company Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What is the history of Perrigo Company?

Perrigo Company plc, a global leader in consumer self-care, began its journey in 1887. Founded by Luther Perrigo, the company's initial focus was on packaging and distributing patented medicines and household items to rural areas.

From its origins as a repackager of home remedies, Perrigo has grown into a significant force in the consumer self-care market. The company now develops, manufactures, and markets a wide array of over-the-counter health and wellness products.

The company's evolution is a story of strategic growth and adaptation. For instance, its early work in providing accessible healthcare solutions laid the groundwork for its future product development, including offerings that would later be analyzed within a Perrigo Company BCG Matrix. In 2023, Perrigo reported net sales of approximately $4.7 billion, reflecting its substantial presence in markets across the United States, Europe, and Australia.

The Perrigo Company's story begins in 1887 in Allegan, Michigan, founded by Luther Perrigo and his brother Charles. Luther, already involved in a general store and apple-drying, saw a chance to supply country stores with packaged patented medicines and household goods.

The Genesis of Perrigo

Perrigo Company history traces its roots to a visionary entrepreneur, Luther Perrigo, who established the business in 1887. The initial focus was on providing essential home remedies and over-the-counter products to rural communities.

• Founded in 1887 by Luther and Charles Perrigo in Allegan, Michigan.
• Initial business model focused on packaging and distributing patented medicines and household items.
• Pioneered the 'private label' concept, allowing stores to imprint their names on products.
• Incorporated in 1892 and remained family-owned for 90 years.
• Early mission centered on affordability and accessibility of healthcare products.

The Perrigo founder, Luther Perrigo, recognized the need for accessible and affordable healthcare products. The company's early success was significantly driven by its innovative 'private label' strategy. This approach allowed general stores to brand products like epsom salts and bay rum with their own names at no extra charge, fostering customer loyalty and differentiating them from competitors. This strategy was a key element in the Perrigo Company's early growth history, setting it apart in the late 19th-century market. Understanding the Competitors Landscape of Perrigo Company at the time highlights the distinctiveness of this approach.

Perrigo Company SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The Perrigo Company history is one of consistent growth and strategic adaptation, beginning with its early expansion across the Midwest. This period laid the groundwork for its future as a major player in the healthcare product manufacturing sector.

Early Expansion and Strategic Shift

In its initial years, Perrigo experienced steady growth, extending its reach throughout the Midwest by the early 1920s. A significant turning point arrived in the 1930s when the company transitioned from simply repackaging home remedies to manufacturing its own affordable healthcare products. This pivotal move was initiated by securing its first major private-label customer, solidifying Perrigo's commitment to manufacturing excellence.

Broadening Customer Base and Manufacturing Footprint

The company's customer base evolved significantly, expanding from small general stores to encompass large regional and national drug chains by the mid-1930s. By the 1970s, this reach further extended to include grocery chains and mass merchandisers. Perrigo established its first manufacturing facility in Allegan, Michigan, in 1921, followed by a second plant in 1936, marking key steps in its operational expansion.

Leveraging Rx-to-OTC Switches and Market Leadership

A crucial element driving Perrigo's growth was the advent of Rx-to-OTC switches. This allowed the company to develop and launch store-brand versions of popular medications, including those for pain relief and allergy symptoms. By 1980, Perrigo had solidified its position as the nation's largest private-label manufacturer of health and beauty products, demonstrating its significant market penetration.

Public Offering and International Growth

The company took a major step in its growth trajectory by going public in 1991. International expansion commenced in 1997 with the acquisition of Quimica y Farmacia (Quifa) in Mexico, establishing Perrigo's first manufacturing presence outside the United States. This was followed by further global expansion into the U.K. and Australia. In 2005, Perrigo broadened its product offerings by acquiring Agis Industries, which added generic prescription pharmaceutical products to its portfolio. Additional acquisitions in subsequent years, including those in the U.K., Mexico, Australia, and a producer of infant formula, further diversified its business and market reach, contributing to its Target Market of Perrigo Company.

Perrigo Company PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Perrigo Company history is a narrative of strategic growth and adaptation, marked by pioneering efforts in the store brand over-the-counter (OTC) market. From its early days, the company focused on manufacturing high-quality, affordable alternatives, a strategy that laid the groundwork for its future success. This commitment to value and accessibility has been a consistent theme throughout its evolution.

Perrigo has been a leader in innovation, particularly through its expertise in Rx-to-OTC switches, allowing for the development of store brand equivalents for popular prescription medications. This approach democratized access to essential health products.

Pioneering Store Brands

Perrigo established itself as a leader in the store brand OTC market by focusing on manufacturing and packaging high-quality, affordable alternatives to national brands.

Rx-to-OTC Switches

The company capitalized on the trend of prescription drugs transitioning to over-the-counter availability, creating accessible store brand versions.

Global Expansion Through Acquisition

Strategic acquisitions like Elan Corporation plc and Omega Pharma NV were pivotal in expanding Perrigo's global footprint and diversifying its product offerings.

Advancing Self-Care Access

The acquisition of HRA Pharma brought Opill, the first FDA-approved over-the-counter daily oral contraceptive in the U.S., to market, significantly advancing access to reproductive health options.

Focus on Consumer Self-Care

The divestiture of the Generic Rx segment in 2021 marked a strategic pivot to concentrate on the growing consumer self-care market.

Operational Efficiency Initiatives

'Project Energize,' launched in Q1 2024, represents a commitment to enhancing global investment and operational efficiency to foster greater agility.

Perrigo has navigated significant challenges, including a net loss of $51.6 million in 1998 due to restructuring its personal care business, which was later divested. A notable setback occurred in November 2000 with a $21 million recall of products containing phenylpropanolamine (PPA) following an FDA recommendation.

Restructuring and Divestiture

In 1998, the company experienced a substantial net loss due to restructuring its personal care division, leading to its divestiture in 1999 to sharpen its focus.

Product Recalls

A significant challenge arose in 2000 with a $21 million product recall prompted by FDA recommendations regarding phenylpropanolamine (PPA).

Tax-Related Setbacks

In December 2018, the company's share price experienced its largest single-day drop following a tax claim from Irish Revenue Commissioners.

Market and Regulatory Navigation

The company has consistently adapted to market fluctuations and navigated complex regulatory landscapes to maintain its operational integrity.

Adapting to Infant Formula Market

The company demonstrated resilience in 2024 by successfully recovering its infant formula business, achieving significant sales growth through market share gains and inventory recovery.

Strategic Business Pivots

The sale of its Generic Rx segment in 2021 was a strategic move to better align with its consumer self-care focus, reflecting its ability to make significant business adjustments. For more on the company's guiding principles, see our article on the Mission, Vision & Core Values of Perrigo Company.

Perrigo Company Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The Perrigo Company history is a testament to enduring growth and strategic adaptation, beginning with its founding in 1887 and evolving into a global self-care leader.

Strategic Focus on Self-Care

Perrigo's 'Stabilize, Streamline, and Strengthen' plan guides its future. The company is committed to expanding its product offerings and investing in innovation.

Portfolio Optimization

Divesting non-core assets, like the Dermacosmetics business for up to €327 million, allows for a sharper focus on high-growth self-care markets. This strategic move is expected to finalize in Q1 2026.

Financial Performance and Growth Projections

The company reported a significant 106.9% increase in Q1 2025 adjusted diluted EPS to $0.60. For fiscal year 2025, Perrigo projects organic net sales growth between 1.5% and 4.5% and adjusted diluted EPS growth of 13% to 21%.

Long-Term Vision and Market Position

Despite market challenges, Perrigo is optimistic about its long-term growth, aiming to enhance operating margins and cash flow. This outlook aligns with its founding principle of providing accessible self-care solutions. Understanding the Marketing Strategy of Perrigo Company provides further insight into its market approach.

Perrigo Company Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔